Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

被引：104

作者：

Dubois, Bruno ^{[1
,2
,3
]}

Chupin, Marie ^{[2
]}

Hampel, Harald ^{[1
,2
,3
]}

Lista, Simone ^{[1
,2
]}

Cavedo, Enrica ^{[1
,2
]}

Croisile, Bernard ^{[4
]}

Tisserand, Guy Louis ^{[4
]}

Touchon, Jacques ^{[5
]}

Bonafe, Alain ^{[5
]}

Ousset, Pierre Jean ^{[6
]}

Ameur, Amir Ait ^{[7
]}

Rouaud, Olivier ^{[8
]}

Ricolfi, Frederic ^{[8
]}

Vighetto, Alain ^{[4
]}

Pasquier, Florence ^{[9
]}

Delmaire, Christine ^{[10
]}

Ceccaldi, Mathieu ^{[11
]}

Girard, Nadine ^{[11
]}

Dufouil, Carole ^{[12
]}

Lehericy, Stephane ^{[2
,13
]}

Tonelli, Isabelle ^{[14
]}

Duveau, Francoise ^{[14
]}

Colliot, Olivier ^{[2
]}

Garnero, Line ^{[2
]}

Sarazin, Marie ^{[1
,2
,3
]}

Dormont, Didier ^{[2
,3
,15
]}

机构：

[1] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Inst Memoire & Malad Alzheimer IM2A, Paris, France

[2] CNRS, UMR S975, INSERM, Inst Cerveau & Moelle Epiniere ICM, Paris, France

[3] Univ Paris 06, Sorbonne Univ, Paris, France

[4] Hop Neurol & Neurochirurg P Wertheimer, Lyon, France

[5] CHR Montpellier, F-34059 Montpellier, France

[6] Hop Casselardit, Toulouse, France

[7] Clin Pasteur, Toulouse, France

[8] Hop Gen, Dijon, France

[9] Univ Lille Nord France UDSL, CHRU, Neurol Clin, Lille, France

[10] Hop Roger Salengro, Lille, France

[11] Hop Enfants La Timone, Marseille, France

[12] Univ Bordeaux, Ctr INSERM Epidemiol & Biostat U897, Bordeaux, France

[13] Hop La Pitie Salpetriere, ICM, CENIR, Neuroimaging Unit, Paris, France

[14] Eisai SAS, Paris 2, France

[15] Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France

来源：

ALZHEIMERS & DEMENTIA | 2015年 / 11卷 / 09期

关键词：

Randomized controlled trial; Amnestic MCI; MRI; Volumetric imaging; Donepezil; Rate of atrophy; Hippocampus; Whole brain analysis; Alzheimer's disease; Prodromal Alzheimer's disease; Mild cognitive impairment; Biomarker; Therapy; AMNESTIC SYNDROME; BRAIN LOSS; PROGRESSION; MRI; SEGMENTATION; TRAJECTORIES; VALIDATION; BIOMARKER; TRIAL;

D O I：

10.1016/j.jalz.2014.10.003

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction: The purpose of this study was to study the effect of donepezil on the rate of hippocampal atrophy in prodromal Alzheimer's disease (AD). Methods: A double-blind, randomized, placebo-controlled parallel group design using donepezil (10 mg/day) in subjects with suspected prodromal AD. Subjects underwent two brain magnetic resonance imaging scans (baseline and final visit). The primary efficacy outcome was the annualized percentage change (APC) of total hippocampal volume (left 1 right) measured by an automated segmentation method. Results: Two-hundred and sixteen only subjects were randomized across 28 French expert clinical sites. In the per protocol population (placebo 5 92 and donepezil 5 82), the donepezil group exhibited a significant reduced rate of hippocampal atrophy (APC=-1.89%) compared with the placebo group (APC=-3.47%), P<. 001. There was no significant difference in neuropsychological performance between treatment groups. Discussion: A 45% reduction of rate of hippocampal atrophy was observed in prodromal AD following 1 year of treatment with donepezil compared with placebo. (C) 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

引用

页码：1041 / 1049

页数：9

共 50 条

[11] Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease
Cavedo, Enrica
Grothe, Michel J.
Colliot, Olivier
Lista, Simone
Chupin, Marie
Dormont, Didier
Houot, Marion
Lehericy, Stephane
Teipel, Stefan
Dubois, Bruno
Hampel, Harald
SCIENTIFIC REPORTS, 2017, 7
[12] Differential atrophy along the longitudinal hippocampal axis in Alzheimer's disease for the Alzheimer's Disease Neuroimaging Initiative
Morais-Ribeiro, Rafaela
Almeida, Francisco C.
Coelho, Ana
Oliveira, Tiago Gil
EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 59 (12) : 3376 - 3388
[13] Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline
ten Kate, Mara
Dicks, Ellen
Visser, Pieter Jelle
van der Flier, Wiesje M.
Teunissen, Charlotte E.
Barkhof, Frederik
Scheltens, Philip
Tijms, Betty M.
BRAIN, 2018, 141 : 3443 - 3456
[14] A meta-analysis of hippocampal atrophy rates in Alzheimer's disease
Barnes, Josephine
Bartlett, Jonathan W.
van de Pol, Laura A.
Loy, Clement T.
Scahill, Rachael I.
Frost, Chris
Thompson, Paul
Fox, Nick C.
NEUROBIOLOGY OF AGING, 2009, 30 (11) : 1711 - 1723
[15] Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer's disease
Ringman, John Matthew
Pope, Whitney
Salamon, Noriko
JOURNAL OF NEUROLOGY, 2010, 257 (05) : 839 - 842
[16] The use of hippocampal grading as a biomarker for preclinical and prodromal Alzheimer's disease
Morrison, Cassandra
Dadar, Mahsa
Shafiee, Neda
Collins, D. Louis
HUMAN BRAIN MAPPING, 2023, 44 (08) : 3147 - 3157
[17] Markers of prodromal Alzheimer's disease
de Souza, L. C.
Sarazin, M.
Uspenskaya, O.
Habert, M. -O.
Lamari, F.
Lehericy, S.
Dubois, B.
REVUE NEUROLOGIQUE, 2012, 168 (11) : 815 - 824
[18] Evaluating Alzheimer's Disease Progression Using Rate of Regional Hippocampal Atrophy
Franko, Edit
Joly, Olivier
PLOS ONE, 2013, 8 (08):
[19] Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer's Disease
Dutt, Shubir
Li, Yanrong
Mather, Mara
Nation, Daniel A.
JOURNAL OF ALZHEIMERS DISEASE, 2020, 77 (04) : 1579 - 1594
[20] White matter disruption at the prodromal stage of Alzheimer's disease: Relationships with hippocampal atrophy and episodic memory performance
Remy, Florence
Vayssiere, Nathalie
Saint-Aubert, Laure
Barbeau, Emmanuel
Pariente, Jeremie
NEUROIMAGE-CLINICAL, 2015, 7 : 482 - 492

← 1 2 3 4 5 →